Linda A. Jacobs

Linda A. Jacobs

Auto-generated profile, based on publicly available information

Linda A. Jacobs

Abramson Cancer Center, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, USA

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2016 in The Journal of Community and Supportive Oncology
Verified
Journal Article
Open access
SPSteven Palmer
Steven Palmer
ADAngela DeMichele
Angela DeMichele
MSMarilyn Schapira
Marilyn Schapira
Karen GlanzKaren Glanz
Karen Glanz
ABAbigail Blauch
Abigail Blauch
LJLinda Jacobs
Linda Jacobs

1 April 2024 in JCO Oncology Practice
Verified
Journal Article
Closed access
KLKelsey S. Lau-Min
Kelsey S. Lau-Min
JMJessica Marini
Jessica Marini
NSNishant K. Shah
Nishant K. Shah
DPDonna Pucci
Donna Pucci
ABAbigail N. Blauch
Abigail N. Blauch
LSLawrence N. Shulman
Lawrence N. Shulman
PURPOSE: Capecitabine is an oral chemotherapy used to treat many gastrointestinal cancers. Its complex dosing and narrow therapeutic index make medication adherence and toxicity management crucial for quality care. METHODS: We conducted a pilot study of PENNY-GI, a mobile phone text messaging–based chatbot that leverages algorithmic surveys and natural language processing to promote medication adherence and toxicity management among patients with gastrointestinal cancers on capecitabine. Eligibility initially included all capecitabine-containing regimens but was subsequently restricted to capecitabine monotherapy because of challenges in integrating PENNY-GI with radiation and intravenous chemotherapy schedules. We used design thinking principles and real-time data on safety, accuracy, and usefulness to make iterative refinements to PENNY-GI with the goal of minimizing the proportion of text messaging exchanges with incorrect medication or symptom management recommendations. All patients were invited to participate in structured exit interviews to provide feedback on PENNY-GI. RESULTS: We enrolled 40 patients (median age 64.5 years, 52.5% male, 62.5% White, 55.0% with colorectal cancer, 50.0% on capecitabine monotherapy). We identified 284 of 3,895 (7.3%) medication-related and 13 of 527 (2.5%) symptom-related text messaging exchanges with incorrect recommendations. In exit interviews with 24 patients, participants reported finding the medication reminders reliable and user-friendly, but the symptom management tool was too simplistic to be helpful. CONCLUSION: Although PENNY-GI provided accurate recommendations in >90% of text messaging exchanges, we identified multiple limitations with respect to the intervention's generalizability, usefulness, and scalability. Lessons from this pilot study should inform future efforts to develop and implement digital health interventions in oncology.

9 January 2024 in JACC: Cardiooncology
Verified
Journal Article
Open access
LJLinda A. Jacobs
Linda A. Jacobs
LSLawrence N. Shulman
Lawrence N. Shulman

31 January 2024 in Journal of Cancer Survivorship
Verified
Journal Article
Open access
PDF file
LJLinda A. Jacobs
Linda A. Jacobs
The Cancer Survivorship Program was established at the University of Pennsylvania Cancer Center in 2001. The Cancer Center was renamed the Abramson Cancer Center of the University of Pennsylvania in 2002 and the survivorship program was henceforth known as the ACC Survivorship Program. The program was supported from 2001 to 2004 in part by a seed grant from the Lance Armstrong Foundation (LAF). The LIVESTRONG Survivorship Centers of Excellence Network was created by the LAF in 2005 and the ACC Survivorship Program joined the Network in 2007. The seven nationwide Cancer Centers that comprised the Network were supported by the LAF through 2015. A focus on clinical care, research, and education led the development of the ACC Survivorship Program. The program is currently led by an advanced practice provider (APP) and staffed by medical, surgical, and radiation oncology APPs and collaborating oncologists. This program provides care to adult survivors of pediatric cancers, as well as survivors of adult-onset cancers such as breast, genitourinary/prostate, lymphoma, head and neck, gastrointestinal, thoracic, sarcoma, and central nervous system. Research protocols for survivors of specific cancer diagnoses have been developed and have resulted in collaborative research, publications, and conference presentations. Sustaining the ACC Survivorship Program has been challenging despite strong endorsement of services by patients, families, and providers. Challenges include barriers such as cost restraints, changing cancer center priorities, and a reduced oncology workforce, issues experienced across the country that must be addressed in the years to come.

29 May 2023 in Journal of Health, Population and Nutrition
Verified
Journal Article
Open access
PDF file
EMErin McMenamin
Erin McMenamin
AGAbigail Blauch Gottschalk
Abigail Blauch Gottschalk
DPDonna A. Pucci
Donna A. Pucci
LJLinda A. Jacobs
Linda A. Jacobs
Purpose: To determine to what extent head and neck cancer (HNC) survivors participate in health behaviors (HBs) recommended by the National Cancer Center Network (NCCN®). Methods: Participants identified through the tumor registries at the Abramson Cancer Center (ACC), University of Pennsylvania and affiliated sites. Eligibility: (a) diagnosis and treatment HNC; (b) aged 18 to 70 years; (c) ≥ 1-year post-diagnosis; (d) human papillomavirus (HPV) status confirmed; (e) ability to understand written English. Potential participants received an explanation of the study, informed consent, self-reported questionnaire, and self-addressed stamped envelope. Results: 451 individuals eligible, 102 (23%) agreed to participate, HPV positive (74%). Current smoking rare (7%), historical use common (48%). Current alcohol use common (65%), average 2.1 drinks/day, 12 days/month. 22% binge drank with an average of 3.5 binge-drinking sessions per month. Nutritional behavior mean 7.1 (range 0–16), lower scores indicating better nutrition. Body mass index (BMI) 59% overweight/obese. Adequate aerobic exercise 59%, adequate strength and flexibility 64%. Leisure time activity, 18% sedentary, 19% moderately active, 64% active. All participants reported having a primary care physician, 92% seen in the previous 12 months. Conclusions: Most HNC survivors participated in some HBs. Current smoking rarely reported, binge drinking and high BMI most common negative HBs. Opportunities remain to improve dietary and exercise behaviors. Implications for cancer survivors: The NCCN® has outlined HBs that decrease likelihood of cancer survivors developing comorbidities that could impact overall survival. It is incumbent on healthcare providers to educate and encourage cancer survivors to participate in these HBs.

1 October 1998 in Nursing Forum
Verified
Journal Article
Open access
PDF file
LJLinda A. Jacobs
Linda A. Jacobs
Nursing practice involves the use of different types of knowledge. This article provides an analysis of personal knowing, one type of nursing knowledge. It uses an example from the cancer nursing literature that reflects the creative and expressive dimensions of personal knowing. The author discusses the social/political process used to determine the validity of this way of knowing and comments on the invaluable contribution that the practice of personal knowing and all types of nursing knowledge lend to the discipline of nursing and to the art and science of cancer nursing.